genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
29 March 2018
21 March 2018 Capital Networks - Note on Genedrive's Interim Results
View all reports >
Tuesday April 10, 2018
Genedrive has Hepatitis C test performance data published in leading medical journal
Tuesday April 03, 2018
Genedrive to premiere Hepatitis C test at Asia-Pacific medical exhibition
Tuesday March 27, 2018
Genedrive extends global coverage with new distribution agreement in India
View all news >
© 2017-18 genedrive plc
Don't show this again